spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

Clinical Trial Supply Nordics 2017

7-8 June 2017
Copenhagen, Denmark

As we enter into 2017, various changes in the industry have altered the landscape for clinical trial supply businesses.  With this in mind, our team has developed an extensive and informative agenda to ensure you leave with various concepts to improve your clinical trial supply chain in the ever changing environment.

Effective forecasting, risks of temperature deviation and annex 16 are just some of the latest challenges which many clinical trial supply businesses are facing today; the consequences which can occur due to ineffective strategies can lead to start up delays, stock outs and most importantly rise in costs. At this yearís event, we aim to embark upon these implications and many more to provide all our attendees with valuable insight into innovative strategies to raise the performance of your clinical trial supply operations.


Key Topics to be discussed at this yearís event:
  • Discussing the advantages of reviewing the logistics of clinical trial supply during protocol design to improve efficiency
  • Reviewing strategies of how best to reduce the risk of temperature deviation to avoid clinical product wastage
  • Addressing recent regulatory changes such as Annex 16 to identify new strategies ensuring compliance
  • Strategies to deal with customs clearance in emerging markets to allow successful import/export of IMP


Key Speakers at this yearís event:
  • Annette Bested Toft, Director Clinical Trial Supply Management, Ascendis Pharma (Denmark)
  • Jonas Fransson, Director, Swedish Orphan Biovitrum AB (Sweden)
  • Dan Markusson, Chief Operating Officer, Peptonic Medical AB (Sweden)
  • Britta Smedegaard Andersen, Project Director, NEXT (Denmark)  


Donít miss out on this fantastic opportunity to discover ideas to enhance your clinical trial supply and to network with industry elites! For more information, please visit: http://www.arena-international.com/ctsnordics or email us at: events@arena-international.com.

FREE PLACES reserved for VP/Director/C-Level executive of a Pharma/Biotech/Medical Device company.

 
Print this page
Send to a friend
   
spacer
Industry Events

SMiís 5th Molecular Diagnostics Conference

9-11 July 2018, Holiday Inn Kensington Forum, London, UK

SMi is proud to announce their 5th Molecular Diagnostics conference. The event will take place in central London on Monday 9th and Tuesday 10th July 2018, along with two half-day post-conference workshops taking place on Wednesday 11th July 2018
More info >>

White Papers

Life Cycle of an Analytical Method - a Case Study on the Monocyte Activation Test

Wickham Laboratories Limited

Pyrogens, a heterogeneous group of fever inducing contaminants, are comprised of microbial and non-microbial compounds; e.g. endotoxin (lipopolysaccharide, LPS) produced by Gram-negative bacteria, lipoteichoic acid (LTA) from Gram-positive bacteria, bacterial DNA (CpG-motive), endogenous pyrogens, virus and fungi particles or even fragments of packaging materials, plastic and dust. Contaminat ion wi th pyrogens in pharmaceutical products, biotherapeutics and on medical devices can lead to life threatening fever reactions. To ensure consumer safety, pyrogen testing is mandatory for parenteral products and medical devices.
More info >>


News and Press Releases

rfxcel Covers the Cost of EMVO Onboarding Fees

May 23, 2018 - San Ramon, CA Ė rfxcel Corporation, a technically certified Gateway Provider for the European Medicines Verification Organisation (EMVO) announced today that it will pay the cost of statutory fees payable to EMVO* for all manufacturers (Marketing Authorisation Holders, MAHs) which select rfxcel as their Gateway Provider before June 15th 2018.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement